الفهرس 
introductionOnly 14 pages are availabe for public view
 |  | from | 110 |  |  |
| | | from | 110 | | |
Abstract
Background: Intravenous regional anesthesia (IVRA) is simple, safe and effective technique. Many drugs have been used lidocaine 0.5% is the most commonly used but it has rapid onset and short duration ropivacaine is a new long acting local anesthetic with more residual postoperative analgesia. So, we amid to evaluate whether the use of ropivacaine would improve the quality and duration of IVRA. Methods: This study was carried out on 30 adult patients whom randomly allocated into two groups Lidocaine: patient received 3mg/kg of 0.5%. Ropivacaine: patients received 1.5mg/kg of 0.2%. They continuously monitored with ECG, blood pressure, respiratory rate and sign and symptoms of toxicity onset of loss of sensation and its regaining as well as loss of motor power and its regaining. Onset of postoperative pain and first request of analgesia. Results: From the results of this study, we observed that 0.2% ropivacaine provided effective anesthesia, superior postoperative analgesia and lower CNS side effects. Conclusion: Ropivacaine may serve as local anesthetic for IVRA that could provide prolonged and analgesia with lower toxicity profile improved.